Newsroom

SEATTLE--(BUSINESS WIRE)--Expedia Group (NASDAQ: EXPE) will report its second quarter 2026 results for the period ended June 30, 2026, on Wednesday, August 5, 2026 via an earnings release and accompanying webcast. These items will be available in the Investor Relations section of the company’s corporate website at http://ir.expediagroup.com. The earnings release will post after market close and the webcast will begin at 1:30 PM Pacific Time / 4:30 PM Eastern Time. A replay of the call is expect...

SEOUL, South Korea--(BUSINESS WIRE)--Magnachip Semiconductor Corporation ("Magnachip") (NYSE: MX) announced today that it will report its financial results for the second quarter ended June 30, 2026, on Wednesday, July 29, 2026, after the market closes. The Company will host a corresponding conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. In advance of the conference call, all participants must use the following link to complete the online registration process. U...

VANCOUVER, British Columbia e TORONTO--(BUSINESS WIRE)--STEMCELL Technologies e il Centre for Commercialization of Regenerative Medicine (CCRM) oggi ha annunciato una collaborazione per ampliare l'accesso a materiali di partenza di alta qualità derivati da cellule staminali pluripotenti indotte umane (iPSC), offrendo agli sviluppatori di terapie cellulari di tutto il mondo un percorso più rapido e meno rischioso dalla ricerca alla clinica. Il testo originale del presente annuncio, redatto nella...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit, in a fireside chat hosted by Madison El-Saadi, Ph.D., Healthcare Research Analyst.T...

EXTON, Pa.--(BUSINESS WIRE)--Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, will release its second quarter 2026 results before the market opens on Thursday, August 6, 2026. Senior management will host a webcast to discuss the company’s results at 8:15 a.m. ET. The results press release and link to the webcast will be available prior to the start of the webcast on the company’s investor relations website at investors.bentley.com Webcast and registr...

PASADENA, Calif.--(BUSINESS WIRE)--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today the planned dates for its third quarter 2026 results and conference call. On Wednesday, July 29, 2026, after market close, Tetra Tech intends to announce its third quarter 2026 results. On Thursday, July 30, 2026, at 8:00 a.m. Pacific Time, Tetra Tech plans to host a conference call to presen...

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of The Ensign Group, Inc. (NASDAQ: ENSG) failed to manage The Ensign Group in an acceptable manner, breaching their fiduciary duties to Ensign Group, and whether Ensign Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On June 11, 2026, Muddy Waters Resear...

VANCOUVER, Brits-Columbia & TORONTO--(BUSINESS WIRE)--STEMCELL Technologies en het Centre for Commercialization of Regenerative Medicine (CCRM) hebben vandaag een samenwerking aangekondigd om de toegang tot hoogwaardig uitgangsmateriaal in de vorm van menselijke geïnduceerde pluripotente stamcellen (iPSC’s) te vergroten. Dit geeft ontwikkelaars van celtherapieën wereldwijd een snellere en minder risicovolle oplossing van onderzoek naar de klinische praktijk. Deze bekendmaking is officieel gelde...

VANCOUVER, Colombie-Britannique et TORONTO--(BUSINESS WIRE)--STEMCELL Technologies et le Centre for Commercialization of Regenerative Medicine (CCRM) ont annoncé aujourd’hui un partenariat visant à élargir l’accès à des matériaux de départ de haute qualité issus de cellules souches pluripotentes induites (CSPi) humaines, offrant ainsi aux développeurs de thérapies cellulaires du monde entier une voie plus rapide et moins risquée pour passer de la recherche à la pratique clinique. Dans le cadre...

VANCOUVER, Columbia Británica y TORONTO--(BUSINESS WIRE)--STEMCELL Technologies y el Centre for Commercialization of Regenerative Medicine (CCRM) han anunciado hoy una alianza para ampliar el acceso a materiales de partida de alta calidad a base de células madre pluripotentes inducidas (iPSC) humanas, lo que ofrecerá a los desarrolladores de terapias celulares de todo el mundo una vía más rápida y con menos riesgos desde la investigación hasta la aplicación clínica. El comunicado en el idioma o...